Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
There is an interesting article on Kaiser Health News today discussing the risks associated with “over-testing” of elderly and sometimes very infirm people who are at relatively low risk for specific chronic diseases, including prostate cancer.
Filed under: Diagnosis, Risk | Tagged: aging, life expectancy, mortality, over-testing, risk, screening | 7 Comments »
A new report in the Journal of Clinical Oncology suggests that — at least between 2000 and 2005 — “excessive PSA screening in elderly men with limited life expectancies” was a significant problem, and may remain so today.
Filed under: Diagnosis, Risk | Tagged: age, life expectancy, PSA, screening, testing | 2 Comments »
When men are initially diagnosed with localized prostate cancer, they face numerous management options — including watchful waiting and active surveillance under appropriate circumstances. In general, physicians tend to recommend treatment if the patient’s reasonable life expectancy is 10 years or more.
Filed under: Diagnosis, Management, Risk | Tagged: health, health-adjusted, life expectancy, self-reported | Leave a Comment »
An article in today’s issue of the Journal of the American Medical Association, and the accompanying editorial in the same issue, are getting a lot of media attention — despite the fact that the article is “only” a mathematical analysis of the possible quality of life benefits of active surveillance in low-risk patients compared to [...]
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: active surveillance, life expectancy, low risk | Leave a Comment »
In what can only be described as an unexpected finding, a group of German researchers have documented a greater life expectancy for men diagnosed with early stage prostate cancer than for the male population in general, based on data from the Regensburg cancer registry!
Filed under: Diagnosis, Living with Prostate Cancer, Risk, Uncategorized | Tagged: increase, life expectancy, PSA, survival | 6 Comments »
The recently revised National Comprehensive Cancer Network guidelines for the management of prostate cancer emphasize the importance of life expectancy in estimating individual patient risk of prostate cancer mortality — particularly for those patients with low- and very low-risk disease.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: life expectancy, mortality, prostate cancer-specific | 8 Comments »
Today’s news reports deal with: Active surveillance management strategies and outcomes to date Life expectancy and the appropriateness of treatment Penile rehabilitation post-surgery Testosterone replacement therapy in prostate cancer patients
Filed under: Management, Treatment, Uncategorized | Tagged: active surveillance, life expectancy, penile rehabilitation, testosterone replacement, Treatment, TRT | Leave a Comment »
Today’s news items all focus on issues that are closely connected to the recent and controversial guidelines issued by the US Preventive Services Task Force: The accuracy of current methods for predicting the likelihood of clinically insignificant (indolent) prostate cancer The management of patients found to have incidental prostate cancer on treatment for benign prostatic [...]
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: BPH, cancer, elderly, indolent, insignificant, Kattan, life expectancy, mortality, news, nomogram, patients, prediction, prostate, prostatectomy, radical, survival, update | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site